Clinical trial
Clinical Study on the Efficacy and Safety of CAR-DC in the Treatment of Advanced Solid Tumors
NCT07504445 is registered in ClinicalTrials.gov with Peking University Shenzhen Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study on the Efficacy and Safety of CAR-DC in the Treatment of Advanced Solid Tumors
- Lead sponsor
- Peking University Shenzhen Hospital
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- June 10, 2026
- Completion date
- April 3, 2028
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
advanced solid tumors